Home
Live Updates
Viz.ai, Inc.: CORRECTING and REPLACING Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm : comparemela.com
Viz.ai, Inc.: CORRECTING and REPLACING Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm
New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms Fourth paragraph, first sentence of release should read: Viz AAA uses artificial intelligence to automatically
Related Keywords
United States ,
Americans ,
Jayme Strauss ,
Philip Batista ,
Laurie Masonson ,
Centers For Disease ,
Drug Administration ,
Business Wire ,
Associate Program Director ,
Endovascular Surgery Residency ,
Trihealth Vascular Surgeon ,
Disease Control ,
Viz Platform ,
Diese Gold Aktie ,
Sichern Sie ,
Kcorrecting ,
Eplacing ,
First ,
Eceive ,
Clearance ,
Algorithm ,
Prabdominal ,
Aortic ,
Aneurysm ,
comparemela.com © 2020. All Rights Reserved.